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A bs tr ac t
Background
Studies of weight-control diets that are high in protein or low in glycemic index have 
reached varied conclusions, probably owing to the fact that the studies had insuf-
ficient power.
Methods
We enrolled overweight adults from eight European countries who had lost at least 
8% of their initial body weight with a 3.3-MJ (800-kcal) low-calorie diet. Participants 
were randomly assigned, in a two-by-two factorial design, to one of five ad libitum 
diets to prevent weight regain over a 26-week period: a low-protein and low-glycemic-
index diet, a low-protein and high-glycemic-index diet, a high-protein and low-
glycemic-index diet, a high-protein and high-glycemic-index diet, or a control diet.
Results
A total of 1209 adults were screened (mean age, 41 years; body-mass index [the weight 
in kilograms divided by the square of the height in meters], 34), of whom 938 entered 
the low-calorie-diet phase of the study. A total of 773 participants who completed 
that phase were randomly assigned to one of the five maintenance diets; 548 com-
pleted the intervention (71%). Fewer participants in the high-protein and the low-
glycemic-index groups than in the low-protein–high-glycemic-index group dropped 
out of the study (26.4% and 25.6%, respectively, vs. 37.4%; P = 0.02 and P = 0.01 for the 
respective comparisons). The mean initial weight loss with the low-calorie diet was 
11.0 kg. In the analysis of participants who completed the study, only the low-
protein–high-glycemic-index diet was associated with subsequent significant weight 
regain (1.67 kg; 95% confidence interval [CI], 0.48 to 2.87). In an intention-to-treat 
analysis, the weight regain was 0.93 kg less (95% CI, 0.31 to 1.55) in the groups as-
signed to a high-protein diet than in those assigned to a low-protein diet (P = 0.003) and 
0.95 kg less (95% CI, 0.33 to 1.57) in the groups assigned to a low-glycemic-index 
diet than in those assigned to a high-glycemic-index diet (P = 0.003). The analysis 
involving participants who completed the intervention produced similar results. The 
groups did not differ significantly with respect to diet-related adverse events.
Conclusions
In this large European study, a modest increase in protein content and a modest re-
duction in the glycemic index led to an improvement in study completion and main-
tenance of weight loss. (Funded by the European Commission; ClinicalTrials.gov 
number, NCT00390637.)
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T he importance of the composition of a diet for the prevention and manage-ment of obesity is debated. Ad libitum con-
sumption of low-fat diets results in short-term 
weight loss,1 and low-carbohydrate, high-protein, 
and high-fat diets (e.g., the Atkins diet) may result 
in substantial weight loss as compared with that 
achieved with other types of diets.2 However, 
the weight loss is generally not sustained beyond 
1 year.3 Greater weight loss with low-carbohy-
drate diets may be ascribed to the satiating effects 
of high protein content,4 and there is increasing 
interest in the efficacy of diets that have a high 
protein content with a moderate carbohydrate and 
fat content.5-7
A diet with a low glycemic index may have 
beneficial effects on body weight and body com-
position8,9 and on certain risk factors in over-
weight persons,9,10 but the effectiveness of ad libi-
tum consumption of low-glycemic-index diets for 
weight control is controversial.9 The Diet, Obesity, 
and Genes (Diogenes) study is a pan-European, 
multicenter, randomized, dietary-intervention 
study designed to assess the efficacy of moderate-
fat diets that vary in protein content and glycemic 
index for preventing weight regain and obesity-
related risk factors after weight loss. We report 
here the results of the 26-week weight-mainte-
nance intervention phase of the study.
Me thods
Study Protocol
The study design, methods, and procedures have 
been described in detail previously.11 The study was 
conducted in eight European countries: Denmark, 
the Netherlands, the United Kingdom, Greece 
(Crete), Germany, Spain, Bulgaria, and the Czech 
Republic. The overall study leaders, together with 
the principal investigator at each study center, de-
signed the study. The principal investigator at each 
study center collected the local data, which were 
entered into a data-registration system (EpiData)12 
and transferred to a central data hub. The Euro-
pean Commission Food Quality and Safety Prior-
ity of the Sixth Framework Programme (the main 
sponsor of the study) had no role in the design of 
the study or in the analysis or interpretation of the 
data. The protocol, including the statistical analy-
sis plan, is available with the full text of this arti-
cle at NEJM.org. The authors attest that the study 
was performed in accordance with the protocol 
and the statistical analysis plan.
Study Participants
Families that included at least one healthy child 
between 5 and 17 years of age and at least one 
parent between 18 and 65 years of age who was 
overweight or obese (body-mass index [the weight 
in kilograms divided by the square of the height 
in meters] of at least 27 and less than 45) were 
recruited for the study. Overweight or obese par-
ents who had achieved the targeted weight loss 
(≥8% of their baseline weight) during the 8-week 
low-calorie-diet period were randomly assigned 
with their families to one of five maintenance diets 
for 26 weeks; randomization was performed with 
the use of a simple block randomization procedure 
with stratification.11 Of 1209 adults screened, 938 
started the low-calorie-diet period. After comple-
tion of this phase of the study, 773 participants 
entered the weight-maintenance phase (Fig. 1). Re-
sults for nonobese adults and children in the study 
families are not reported here.
Weight-Loss Phase
During the 8-week weight-loss phase, participants 
received a low-calorie diet that provided 3.3 MJ 
(800 kcal) per day with the use of Modifast prod-
ucts (Nutrition et Santé). Participants could also 
eat up to 400 g of vegetables, providing a total, 
including the low-calorie diet, of 3.3 to 4.2 MJ 
(800 to 1000 kcal) per day.
Weight-Maintenance Phase
In the randomized maintenance phase, which was 
initiated immediately after participants completed 
the weight-loss phase, participants were assigned 
to one of five diets, in a two-by-two factorial de-
sign: a diet that was low in protein (13% of total 
energy consumed) with a low glycemic index, a diet 
that was low in protein with a high glycemic index, 
a diet that was high in protein (25% of total ener-
gy consumed) with a low glycemic index, a high-
protein and high-glycemic-index diet, or a con-
trol diet. The control diet, which followed dietary 
guidelines in each participating country, had a 
moderate protein content and did not include in-
structions to participants with respect to the gly-
cemic index.
Study participants were instructed to maintain 
their weight loss during this phase, although fur-
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ther weight reduction was allowed. All five diets 
were designed to have a moderate fat content (25 
to 30% of total energy consumed) with no restric-
tions on energy intake (i.e., ad libitum diets), in 
order to test the ability of the diets to regulate 
appetite and body weight. We targeted a differ-
ence of 15 glycemic-index units between the 
high-glycemic-index diets and the low-glycemic-
index diets and a difference of 12% of total en-
ergy consumed from protein between the high-
protein diets and the low-protein diets. Visits for 
dietary counseling took place every other week 
during the first 6 weeks and monthly thereafter. 
The families were provided with recipes, cooking 
and behavioral advice, and a point-based teach-
ing system to achieve the targeted macronutrient 
compositions.13
In Maastricht and Copenhagen (“shop cen-
ters”), the families received dietary instruction 
plus free foods from the laboratory shop for 26 
weeks so that we could assess the effect that 
the provision of food would have on adherence. 
In the other six centers (“instruction centers”), 
the families were provided with dietary instruc-
tion only.14,15 Local sponsors made financial 
contributions to the shop centers, and food 
manufacturers provided a number of foods free 
of charge. The local sponsors and food manufac-
773 Underwent randomization
781 Were weighed before randomization
for maintenance intervention
8 Were excluded because they did not have a
weight loss ≥8% during LCD phase
938 Were weighed before 8-wk LCD phase
157 Withdrew before randomization
1209 Subjects were screened for participation
271 Withdrew or did not meet inclusion criteria
150 Were assigned
to LP–LGI diet
44 Dropped out
 (29.3%)
150 Were included in
the intention-to-
treat population
106 Completed the
intervention
155 Were assigned
to LP–HGI diet
58 Dropped out
(37.4%)
155 Were included in
the intention-to-
treat population
97 Completed the
intervention
159 Were assigned
to HP–LGI diet
35 Dropped out
(22.0%)
159 Were included in
the intention-to-
treat population
124 Completed the
intervention
155 Were assigned
to HP–HGI diet
48 Dropped out
(31.0%)
155 Were included in
the intention-to-
treat population
107 Completed the
intervention
154 Were assigned
to control diet
40 Dropped out
(26.0%)
154 Were included in
the intention-to-
treat population
114 Completed the
intervention
Figure 1. Screening, Randomization, and Follow-up of Study Participants.
HGI denotes high glycemic index, HP high protein, LCD low-calorie diet, LGI low glycemic index, and LP low protein. 
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turers had no influence on the selection of foods 
found in the two shops, nor were they involved in 
designing the study or in analyzing and interpret-
ing data.
Monitoring Food Intake
The study participants weighed their food and 
completed food diaries for 3 consecutive days at 
the time of screening (9 to 11 weeks before ran-
domized assignment to the maintenance interven-
tion), 4 weeks after randomization, and at the end 
of the 26-week intervention. The calculation of nu-
trient intake was performed with the use of local 
food databases, as described previously.11 Coding 
of food according to the glycemic index was per-
formed separately from coding according to nu-
trient intake. Values for the glycemic index were 
based on glucose as a reference, as described pre-
viously.16 Blood samples were obtained before the 
intervention and at the end of the intervention, 
and urine samples before the intervention, at weeks 
4 and 14, and at the end of the intervention, to as-
sess adherence to the diet.11 A description of the 
method used for performing urinary analyses is 
provided in the Supplementary Appendix, available 
at NEJM.org.
Statistical Analysis
Estimates of the sample size were calculated with 
the assumption that after the 26-week intervention, 
the smallest difference in weight change (esti-
mated to be 1.0 kg) that would be detected among 
the diet groups would be found between the groups 
assigned to low-glycemic-index diets and the 
groups assigned to high-glycemic-index diets. We 
estimated that a sample of 918 adults would be 
needed to detect a significant difference between 
the high-glycemic-index and low-glycemic-index 
groups, assuming a dropout rate of 20%.11
Dietary intakes were calculated for participants 
who completed food diaries, and changes from 
screening to the end of the intervention phase were 
calculated only for study participants who com-
pleted food diaries at both those times (393 par-
ticipants). Mean intakes of energy and macronutri-
ents, the glycemic index, and the glycemic load 
were compared with the use of one-way analysis of 
variance. When an overall significant difference in 
the effect of dietary group was found, pairwise 
comparisons of the groups were performed with 
Sidak’s adjustment for multiple comparisons.
The intention-to-treat analysis included data 
from all participants who underwent randomiza-
tion. To account for bias resulting from different 
rates of dropout among the groups, we used a 
mixed model to evaluate the weight changes (as-
sessed at eight time points during the 26-week 
intervention). This intention-to-treat model pro-
vides unbiased results under the assumption that 
missing data were missing at random.17 The 
model considered all available weight recordings 
during the intervention for all participants who 
underwent randomization and assumed that the 
weight changes in participants who dropped out of 
the study followed the same course. The analy-
ses were adjusted for the body-mass index at the 
time of randomization and the change in body 
weight from the beginning of the low-calorie-diet 
phase to the time of randomization as covariates 
and diet group, sex, and type of center (shop or 
instruction) as factors. The interactions between 
diet and sex and between diet and type of center 
were included in the model. It was assumed that 
the correlation between weight regain at two vis-
its decreased with the number of weeks between 
the visits and that the decrease per week was 
constant.
The completion analysis, which included all 
participants for whom data were available from 
both the time of randomization and the end of 
the trial intervention, was performed with the 
use of analysis of covariance. In addition, a lin-
ear regression analysis was performed to test the 
main effects of protein and glycemic index sepa-
rately. In both analyses, we adjusted for the same 
covariates as in the intention-to-treat analysis 
described above, as well as for the length of time 
between randomization and the end of the inter-
vention.
The influence of center, type of center (shop 
or intervention), sex, age at screening, body-mass 
index at the time of randomization, body weight 
lost during the low-calorie-diet phase, family type 
(single-parent family, two-parent family with 
one parent as participant, or two-parent family 
with both parents as participants), and diet on 
the dropout rate during the maintenance phase 
was analyzed with the use of a logistic model.
Results are presented as means ±SD, and es-
timates of effects as means and 95% confidence 
intervals. Two-tailed P values of less than 0.05 
were considered to indicate statistical signifi-
cance. The analyses were performed with the 
use of SAS software, version 9.1.
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R esult s
Study Participants
The participants in the five diet groups were well 
matched with respect to characteristics at baseline 
(i.e., at the beginning of the low-calorie-diet phase) 
and at the time of randomization, with no signifi-
cant between-group differences in changes during 
the low-calorie-diet phase (Table 1). During the 
dietary-intervention period, 225 of the 773 partici-
pants who had undergone randomization (29%) 
dropped out of the study (Fig. 1). The dropout rate 
was lower in the groups that were assigned to high-
protein diets and the groups that were assigned to 
low-glycemic-index diets than in the group that 
was assigned to the diet that was low in protein 
and had a high glycemic index (26.4% and 25.6%, 
respectively, vs. 37.4%; P = 0.02 and P = 0.01 for the 
two comparisons, respectively). The low-glycemic-
index diets were associated with a lower risk of 
dropout than were the high-glycemic-index diets 
(odds ratio, 0.64; 95% confidence interval [CI], 0.44 
to 0.92; P = 0.02), and there was a trend toward a 
lower risk of drop-out with the high-protein diets 
than with the low-protein diets (odds ratio, 0.69; 
95% CI, 0.48 to 1.00; P = 0.05).
Dietary Intake
Dietary intakes for all groups are shown in Table 
2. The proportion of total energy consumed from 
protein was 5.4 percentage points higher, and the 
proportion of total energy consumed from carbo-
hydrates was 7.1 percentage points lower, in the 
high-protein groups than in the low-protein groups 
(P<0.001 for both comparisons). The mean glyce-
mic index in the low-glycemic-index groups was 
only 5 units lower than that in the high-glycemic-
index groups (P<0.001). There was a 71% (20.6-g-
per-day) greater reduction in the glycemic load in 
the high-protein groups than in the low-protein 
groups (P = 0.002). There were no significant dif-
ferences among the groups in the recordings of 
subjective appetite sensations (data not shown).
Markers of Adherence to Diet
The urinary excretion of nitrogen during the main-
tenance period was greater by 2.09 g per 24 hours 
in the high-protein groups than in the low-protein 
groups (P<0.001) (Fig. 2A), and the difference re-
mained significant when the analysis included 
only participants from whom more than 500 ml of 
urine had been collected and more than 80% but 
less than 120% p-aminobenzoic acid had been 
recovered. In addition, the plasma urea concentra-
tion was higher in the high-protein groups than in 
the low-protein groups (between-group difference, 
0.27 mmol per liter; P = 0.01).
Body Weight
Intention-to-Treat Analysis
The intention-to-treat analysis, performed with the 
use of a mixed linear model, included all 773 par-
ticipants who underwent randomization, of whom 
705 attended at least one visit after randomiza-
tion. The weight increase during the maintenance 
period was 0.93 kg (95% CI, 0.31 to 1.55) higher 
in the low-protein groups than in the high-protein 
groups (P = 0.003) and 0.95 kg (95% CI, 0.33 to 
1.57) higher in the high-glycemic-index groups 
than in the low-glycemic-index groups (P = 0.003) 
(Fig. 2B). There was no significant interaction be-
tween the high-protein diets and the low-glycemic-
index diets. We performed a sensitivity analysis, 
assuming a 1-kg weight gain per month in par-
ticipants who had dropped out of the study. This 
analysis produced similar results — a weight in-
crease that was 1.01 kg (95% CI, 0.24 to 1.78) 
higher in the low-protein groups than in the high-
protein groups (P = 0.01) and 0.99 kg (95% CI, 
0.22 to 1.76) higher in the high-glycemic-index 
groups than in the low-glycemic-index groups 
(P = 0.01). The high-protein groups were more like-
ly to achieve an additional weight loss of more 
than 5% of their body weight at randomization 
than were the low-protein groups (odds ratio, 
1.92; 95% CI, 1.06 to 3.45; P = 0.03), and the low-
glycemic-index groups were more likely to achieve 
an additional weight loss of more than 5% than 
were the high-glycemic-index groups (odds ratio, 
2.54; 95% CI, 1.38 to 4.66; P = 0.003) (Table 3).
Completion Analysis
In the analysis of 548 participants who complet-
ed the intervention, the mean (±SD) weight regain 
was 0.56±5.44 kg. Only the participants assigned 
to the diet that was low in protein with a high gly-
cemic index had significant weight regain (1.67 kg; 
95% CI, 0.48 to 2.87) (Table 2). The changes in 
body weight differed among the diet groups 
(P = 0.01 by analysis of covariance). The isolated 
effect size of the high-protein diets as compared 
with the low-protein diets was 1.44 kg (95% CI, 
0.50 to 2.33; P=0.02). The effect size of the low-
glycemic-index diets as compared with the high-
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glycemic-index diets was 1.09 kg (95% CI, 0.18 to 
2.00; P = 0.02). The effects of protein and glycemic 
index on body-weight changes in the shop centers 
were consistent with the results in the instruc-
tion centers, but analyzing the centers separately 
reduced the statistical power. In the shop centers, 
the high-protein groups gained 2.7 kg less body 
weight than did the low-protein groups (P<0.001), 
whereas the difference was 0.54 kg in the instruc-
tion centers (P = 0.13). In the shop centers, the low-
glycemic-index groups gained 0.48 kg less than did 
the high-glycemic-index groups (P = 0.48), where-
as the difference was 1.03 kg in the instruction 
centers (P = 0.004).
Adverse Events
Four serious adverse events were reported during 
the weight-maintenance period. One person as-
signed to the low-protein–low-glycemic-index diet 
presented with lower abdominal pain but recov-
ered without the need for hospitalization. Another 
person assigned to the low-protein–low-glycemic-
index diet who presented with abdominal pain 
and two persons assigned to the low-protein–high-
glycemic-index diet who presented with upper 
abdominal pain were hospitalized; each had his or 
her gall bladder removed and recovered without 
further consequences. The number of adverse 
events was lower in the group assigned to the diet 
that was low in protein with a high glycemic index 
than in any of the other groups, but the pattern 
of adverse events does not suggest any causal re-
lation to the diet (for further details on adverse 
events, see the Supplementary Appendix).
Discussion
In this study, the rate of completion of the inter-
vention and the rate of maintenance of weight loss 
were higher among participants who were assigned 
to the high-protein diets and to the low-glycemic-
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Figure 2. Total 24-Hour Urinary Nitrogen Excretion 
and Changes in Body Weight.
Panel A shows 24-hour urinary nitrogen excretion, as  
a marker of dietary protein intake, from the time before 
the low-calorie diet (LCD) was initiated through the 
end of the weight-maintenance intervention. Panel B 
shows the change in weight for each of the dietary 
groups during the weight-maintenance intervention, 
adjusted for body-mass index at randomization, weight 
loss during the low-calorie-diet phase, sex, family type 
(single-parent family, two-parent family with one par-
ent as participant, or two-parent family with both par-
ents as participants), center, and age at screening, on 
the basis of an intention-to-treat mixed-model analysis. 
The changes in body weight from randomization to 
week 26 among participants who completed the inter-
vention are also shown (boxes). All partic ipants who 
underwent randomization and for whom data on 
weight at the time of randomization were available 
were included. HGI denotes high glycemic index, HP 
high protein, LGI low glycemic index, and LP low protein.
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index diets than among those who were assigned 
to the low-protein diets and to the high-glycemic-
index diets (with no restrictions on energy intake 
in any of the diets). In addition, the participants 
assigned to the diet that was high in protein with 
a low glycemic index continued to lose weight 
after the initial weight loss. The higher protein 
content was achieved by reducing the carbohy-
drate content, which adds further support to the 
concept that reducing the glycemic load (defined 
as carbohydrate content times glycemic index) is 
important for controlling body weight in obese 
patients.8,18,19 No differences were detected in 
self-perceived satiety, though we suspect that the 
effects were too subtle to be subjectively per-
ceived or measured with the use of visual-ana-
logue scales.
The dietary intervention was carefully con-
trolled to avoid differences in total fat, alcohol, 
and fiber among the groups but did not fully 
achieve the targeted difference of approximately 
12% of total energy consumed in protein between 
the high-protein and the low-protein groups or the 
targeted difference of approximately 15 glycemic-
index units between the low-glycemic-index and 
the high-glycemic-index groups. The differences 
that were achieved in the study were 5.4 percent-
age points of total energy in protein content 
between the high-protein and the low-protein 
groups and 4.7 glycemic-index units between the 
low-glycemic-index and the high-glycemic-index 
groups.
Measurement of urinary nitrogen excretion 
confirmed adherence to the diets (high-protein 
vs. low-protein), but adherence decreased toward 
the end of the study. Suboptimal adherence, per-
haps owing to insufficient knowledge of the 
content of local foods, may have accounted for 
the failure to reach the targeted differences in 
protein and glycemic index. However, the results 
indicate that even a modest increase in dietary 
protein or a modest reduction in glycemic-index 
values was sufficient to minimize weight regain 
and promote further weight loss in obese pa-
tients after a successful weight-loss diet. Higher 
dietary adherence might have resulted in even 
greater weight loss.
We used families as the unit of randomiza-
tion, since we thought that adult participants 
would be more likely to adhere to the diet if the 
entire family had the same diet. The participants 
who underwent randomization in our study were 
probably a more adherent group than partici-
pants in other studies, since they had adhered 
sufficiently to the low-calorie diet (3.3 MJ [800 
kcal] per day) for 8 weeks to lose at least 8% of 
their body weight. Despite issues of adherence, 
we believe that our results are generalizable to 
obese people, particularly if diets are facilitated 
by easy access to low-glycemic-index foods and 
a culture that supports these dietary changes.
The dropout rate (29%) was higher than the 
expected rate of 20%,11 possibly owing to diffi-
culty in maintaining motivation in whole fami-
lies over the course of the 26 weeks of the study. 
Other dietary studies have reported similar drop-
out rates.3,18
We conducted a smaller study with the shop 
model and ad libitum food, and we found that 
after a 6-month intervention, a high-protein diet 
resulted in weight loss that was 3.7 kg greater 
than that achieved with a low-protein diet.19 The 
current study aimed to investigate whether par-
ticipants who have had a major weight loss could 
maintain the lower weight; the results of the 
study are similar to those of McMillan-Price et 
al., who found that participants following high-
protein diets lost about 0.6 kg more than did 
participants following low-protein diets over the 
course of 3 months.20
A reduction in the glycemic index of 4.7 units 
resulted in a 0.95-kg difference in body weight 
between the high-glycemic-index groups and the 
low-glycemic-index groups. Since there were no 
differences in fiber intake, the difference in 
body weight, though small, can be ascribed to a 
true effect of the glycemic index. This difference 
is consistent with results from a previous study.21 
Furthermore, a Cochrane meta-analysis of inter-
vention studies showed that there was a 1.1-kg 
greater weight loss with low-glycemic-index di-
ets than with high-glycemic-index diets.9 How-
ever, previous studies were designed to investigate 
weight loss, not weight maintenance, rendering 
direct comparisons difficult. McMillan-Price et al. 
did not observe a significant difference in weight 
loss between diets that differed by 20 glycemic-
index units.20 Sloth et al. found a 0.6-kg (nonsig-
nificant) difference between diets that differed 
by 24 glycemic-index units.22 Philippou et al. 
found no significant differences in weight change 
between maintenance diets that differed by 14 
glycemic-index units (approximately 1.0 kg).23
The effects of protein and the glycemic index 
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on changes in body weight that we found in the 
shop centers were consistent with those at the in-
struction centers. However, subgroup analyses 
suggested that the high-protein diets were more 
effective at the shop centers, whereas the low-
glycemic-index effect was greater at the instruc-
tion centers. The control diet was designed accord-
ing to guidelines in each participating country and 
provided a slightly higher proportion of calories 
from protein than that in the low-protein groups 
(19% vs. 17% of total energy consumed), with a 
glycemic index between the high-glycemic-index 
and low-glycemic-index diets. Thus, the change in 
body weight that was observed in the control 
group was as expected, given the protein content 
and glycemic-index value of the diet. Weight re-
gain in our study was relatively low (0.56 kg), 
and the overall weight loss in all participants 
who completed the intervention was therefore 
quite high (10.6 kg), as compared with the total 
weight loss in most studies of similar length.
In conclusion, in this large, randomized study, 
a diet that was moderately high in protein content 
and slightly reduced in glycemic index improved 
the rate of completion of the intervention and 
maintenance of weight loss and therefore appears 
to be ideal for the prevention of weight regain.
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